Texas Update in Cardiovascular Advancements 2020

Saturday | January 18, 2020
19th TEXAS UPDATE IN CARDIOVASCULAR ADVANCEMENTS 2020

Overview

Course Director: James T. Willerson, MD

Over the past decade, physicians and scientists have worked diligently to find ways to combat the various physiological and behavioral risk factors and the genetic alterations associated with cardiovascular disease. This one-day symposium features lectures and discussions by distinguished faculty who provide current information on the status and future directions of cardiovascular medicine.

 

Faculty

James. T. Willerson, MD Course Director

President Emeritus, Texas Heart Institute
(Houston, Texas)

Director, Texas Heart Institute Center for Women’s Heart and Vascular Health
Associate Director, Non-Invasive Cardiology
Texas Heart Institute; CHI St. Luke’s Health – Baylor St. Luke’s Medical Center
Cardiologist, Leachman Cardiology Associates
(Houston, Texas)

Director, Interventional Cardiology Research and Education
CHI St. Luke’s Health - Baylor St. Luke’s Medical Center
Texas Heart Institute
(Houston, Texas)

Director, Cardomyocyte Renewal Laboratory, Texas Heart Institute
Houston, Texas
Vivian L. Smith Professor
Baylor College of Medicine
(Houston, Texas)

Professor of Medicine
UT Southwestern Medical Center
(Dallas, Texas)

Assistant Professor of Medicine Atherosclerosis and Vascular Medicine
Baylor College of Medicine
(Houston, Texas)

Medical Director, Texas Heart Institute
CHI St. Luke’s Health - Baylor St. Luke’s Medical Center
(Houston, Texas)

Cardiologist and Electrophysiologist
CHI St. Luke’s Health - Baylor St. Luke’s Medical Center
Texas Heart Institute
(Houston, Texas)

Professor in Medicine and Genetics
Harvard Medical School
Brigham and Women's Hospital
(Boston, Massachusetts)

Director, Structural Heart Disease
Baylor College of Medicine;
Assistant Director, Stem Cell Center,
CHI St. Luke’s Health - Baylor St. Luke’s Medical Center
Texas Heart Institute
(Houston, Texas)

Program Overview

Heart and vascular disease are the #1 killers throughout the world for men, women and children.  A death from heart or vascular disease occurs every 33 seconds, with 2600 deaths occurring each day, and more than one million deaths occurring each year. There are 40 million women in the United States presently living with heart or vascular disease.  In contrast, there are 8 million women living with cancer in the US presently.  A woman is 5 times more likely to die of heart attack than of breast cancer.  More women die of heart and vascular disease then of all cancers combined.  A young person dies on the playing fields in the US every 2 to 3 weeks.  These deaths are almost always caused by underlying but previously unsuspected heart and vascular disease.

 

Over the past decade, physicians and scientists have worked diligently to find ways to combat the various physiological and behavioral risk factors and the genetic alterations associated with cardiovascular disease. Our one-day symposium will feature lectures and discussions by distinguished faculty who will provide current information on the status and future directions of cardiovascular medicine.  The faculty will highlight recent progress in the diagnosis and treatment of cardiovascular disease, as well as new therapeutic modalities.

Target Audience

The audience for this continuing medical education activity includes cardiologists, cardiovascular surgeons, internists, clinical researchers, nurses, technicians, and all interested in cardiovascular disease.

Agenda

19th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium

All presentations are followed by Q&A with the speaker

7:30 am      Continental Breakfast and Exhibits

8:00            Welcome and Introductions|  James T. Willerson, MD

8:15             Update on PCSK9 Inhibitors in Treating Elevated LDL| Vijay Nambi, MD, PhD

 8:45            Discussion

9:00             Advances with TAVR: Should it Replace Surgery for most Patients with Valvular Aortic   Stenosis? | R. David Fish, MD

9:30            Discussion

9:45             Catheter Based Repairs of the Mitral Valve: What is the Best Approach| Guilherme V. Silva, MD

10:15            Discussion

10:30           Break

10:45           Treating Ventricular Arrythmias by Catheter | Mohammad Saeed, MD

11:15            Discussion


Presentation of Ray C. Fish Award and Luncheon | Texas Heart Institute The Ansary Atrium

11:30- 1:15        Luncheon and Award Presentation


19th Texas Update in Cardiovascular Advancements | Denton A. Cooley Auditorium

1:30 pm       Ray C. Fish Lecture

                 Molecules, Mechanisms and New Medicines for Hypertrophic Cardiomyopathy

                Christine Edry Seidman, MD
                 Harvard Medical School
                 Departmentt of Genetics
                 Boston, Massachusetts

2:00        Treating Post-Menopausal Women with Hormonal Therapy: What is Safest and Best? | Stephanie Coulter, MD

2:30        Discussion

2:45        Will Treatment of Heart Failure Include Allegenic Mesenchymal Stem Cells with FDA Approval in 2020 and Beyond? | Emerson Perin, MD, PhD

3:15         Discussion

3:30        Advances in Treating Heart Failure by Stimulating Cardiogenesis Directly in Preclinical Models with Ischemic Injury and CHF | James F. Martin, MD, PhD

4:00       Discussion

4:15        The Role of Inhibitors of Glucose and Sodium Transport in the Treatment of Heart Failure |  Darren K. McGuire, MD, M.H.Sc.

4:45       Discussion

5:00        Final Summary | James T. Willerson, MD

Objectives & Credit Designation

At the conclusion of this symposium, participants should be able to –

  • Discuss the latest advances in cardiovascular disease
  • Discuss recent scientific advances in lipid management and the use of statins for acute and chronic
  • Recognize the potential therapeutic options with stem cell therapy for cardiovascular disease, including congestive heart failure
  • Be aware of potential new approaches to stimulate cardiogenesis already in the treatment of heart failure
  • Discuss the use of stem cell therapy in the regeneration of damaged heart tissue
  • Highlight new advances in electrophysiology, including biventricular pacing, defibrillation, and ablation for arrhythmias
  • Discuss heart disease in women
  • Discuss TAVR to treat valvular aortic stenosi

Accreditation:

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Texas Heart Institute designates this live activity for a maximum of 6.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Maintenance of Certification (MOC):

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Lodging

Meeting Location

The symposium is held in the Texas Heart Institute – The Denton A. Cooley Building located within the Texas Medical Center at 6770 Bertner Avenue, Houston, Texas 77030.

Entrance to the Denton A. Cooley Building is only through the Baylor St. Luke’s Medical Center Bates Street lobby (6720 Bertner Ave.).

The meetings will be held in The Denton A. Cooley auditorium located on the lower level of the Cooley Building which is accessible by the Green Elevators.

Lodging

There are several hotels in the Texas Medical Center within walking distance or short taxi.

Marriott Medical Center 
6580 Fannin Street
Houston, TX 77030
Phone: 713-796-0080

Hilton Houston Plaza
6633 Travis Street
Houston, TX 77030
Phone: 713-313-4000

Wyndham Hotel & Suites
Houston Medical Center
6800 S. Main Street
Houston TX 77030
Phone: 713-528-7744

Hotel ZAZA
5701 Main Street
Houston, TX 77005
Phone: 713-526-1991

InterContinental Houston – Medical Center
6750 Main St, Houston, TX 77030
Phone: 713- 422-2779

Ground Transportation 

Taxi service to the Texas Medical Center (TMC) hotels from Hobby Airport averages $35 one way. Taxi service from Bush Intercontinental Airport averages $50 one way. Uber & Lyft provide service in Houston. The drive to the TMC is approximately 30 minutes from Hobby Airport and approximately 45 minutes from Bush Intercontinental Airport. Rental car services are also available at both airports.

Parking

Parking for the event is available in Garage 2 located off Holcombe and Bertner for a fee of $13. You may also valet for $14 at the front of Baylor St. Luke’s Medical Center located at 6720 Bertner Avenue.

More information on parking and directions for the Texas Medical Center is available online at www.tmc.edu.